Structural Basis for Isoform Selectivity in a Class of Benzothiazole Inhibitors of Phosphoinositide 3-Kinase gamma.
Collier, P.N., Martinez-Botella, G., Cornebise, M., Cottrell, K.M., Doran, J.D., Griffith, J.P., Mahajan, S., Maltais, F., Moody, C.S., Huck, E.P., Wang, T., Aronov, A.M.(2015) J Med Chem 58: 517-521
- PubMed: 24754609 
- DOI: https://doi.org/10.1021/jm500362j
- Primary Citation of Related Structures:  
4PS3, 4PS7, 4PS8 - PubMed Abstract: 
Phosphoinositide 3-kinase γ (PI3Kγ) is an attractive target to potentially treat a range of disease states. Herein, we describe the evolution of a reported phenylthiazole pan-PI3K inhibitor into a family of potent and selective benzothiazole inhibitors. Using X-ray crystallography, we discovered that compound 22 occupies a previously unreported hydrophobic binding cleft adjacent to the ATP binding site of PI3Kγ, and achieves its selectivity by exploiting natural sequence differences among PI3K isoforms in this region.
Organizational Affiliation: 
Vertex Pharmaceuticals Inc. , 50 Northern Avenue, Boston, Massachusetts 02210, United States.